We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
HER-2/Neu overexpression is a rare event in peri-ampullary cancer: assessment using the HercepTest<sup>TM</sup>.
- Authors
Aloysius, Mark M.; Lobo, Dileep N.; Rowlands, Brian J.; Madhusudan, Sreenivasan; Ilyas, Mohammad; Zaitoun, Abed M.
- Abstract
The article discusses research regarding the significance of overexpression of HER-2/neu in treating pancreatic cancers. It mentions that researchers conducted an immunohistochemistry in order to verify the results of Koeppen et al. in treating pancreatic cancers using trastuzamab. In conclusion, it states that the findings of the researchers coincides with the research of Koeppen et al. which declares that pancreatic cancers rarely overexpress HER-2/neu.
- Subjects
TRASTUZUMAB; PANCREATIC cancer; THERAPEUTIC use of immunoglobulins; IMMUNOHISTOCHEMISTRY; HISTOPATHOLOGY; THERAPEUTICS
- Publication
Histopathology, 2009, Vol 55, Issue 2, p236
- ISSN
0309-0167
- Publication type
Letter
- DOI
10.1111/j.1365-2559.2009.03351.x